Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,435 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07593027RecruitingPhase 1/Phase 2
Study of IMC-003 for pulmonary arterial hypertension
This trial tests a new drug called IMC-003 for people with pulmonary arterial hypertension (PAH). It aims to see if the drug can help improve symptoms and exercise ability when added to your current PAH medications.
Beijing, Beijing MunicipalityAges 18–75 - NCT07586982Recruiting
Testing New Bifocal Toric Contact Lenses for Astigmatism
This study evaluates how well new bifocal contact lenses work for people over 40 who have astigmatism (blurred vision at all distances) and need reading help. You'll wear the lenses daily for about a month and share feedback via text message to help researchers understand comfort and vision quality.
Memphis, TennesseeAges 18–40 - NCT07590180Recruiting
Internet Gaming Habits and Brain Chemistry in Young Teens
This study looks at how excessive video gaming affects the brains and behavior of children ages 10–14. Researchers will compare children who game heavily with those who don't, measuring brain chemicals and decision-making patterns to understand why some kids struggle to control their gaming.
Istanbul, BakirkoyAges 10–14 - NCT07591324Recruiting
3D-Printed vs. Traditional Space Holders for Kids' Teeth
This study compares two types of dental devices that hold space in a child's mouth after baby molars fall out early. The research tests whether a newer 3D-printed version works as well as or better than the traditional wire-based device.
Ismailia, Ismailia GovernorateAges 7–9 - NCT07590310RecruitingEarly Phase 1
CAIX-Targeted PET Imaging Scan for Tumor Diagnosis
This early-stage trial tests a new type of imaging scan (called PET) that uses a special tracer to help doctors see tumors better. The scan targets a protein called CAIX that appears on many cancer cells, which may help with accurate diagnosis and staging.
Beijing, HaidianAges 18–75 - NCT07592325Recruiting
Testing a New Flexible Prosthetic Socket for Below-Knee Amputees
This trial compares a new flexible prosthetic socket design to the rigid socket you currently wear. The goal is to see if the new socket is more comfortable, easier to put on, and improves how well your prosthetic leg works for daily activities.
ClamartAges 18 years+ - NCT06516562Recruiting
Heart failure study in Vietnam: following patients' health over time
This study follows people with heart failure in Vietnam to understand their health and treatment over time. It does not test a new drug—just collects information to improve care.
Ho Chi Minh CityAges 18 years+ - NCT04590560Recruiting
Best timing for breast screening in women ages 45–49 and 70–74
This study looks at the best time interval for breast cancer screening (mammograms) for women in two age groups. The goal is to reduce missed cancers while avoiding unnecessary tests.
Meldola (FC), FCAges 45–49 - NCT05548946Recruiting
Study of personality patterns in adults age 65 and older
This study looks at personality patterns in older adults using information gathered from participants. It may help researchers better understand how these patterns show up later in life.
Tienen, Vlaams-BrabantAges 18 years+ - NCT07579845Recruiting
Dietary supplement study on aging markers and body health
This study tests whether a dietary supplement containing humic and fulvic acids (natural compounds) can improve markers of biological aging, inflammation, and how your body handles toxins. Researchers will check blood samples to see if the supplement affects these markers over time.
Richmond, VirginiaAges 40 years+ - NCT07580547Recruiting
Atrial fibrillation ablation: study on sex differences
This research compares how atrial fibrillation (AF) affects men and women differently. If you are having your first catheter ablation for AF and are between 18 and 80, this study may help doctors understand outcomes better.
Be’er Ya‘aqovAges 18–80 - NCT07581834RecruitingPhase 2
Dalpiciclib plus hormone therapy for early hormone-positive breast cancer
This study tests whether adding a new drug called dalpiciclib to standard hormone therapy improves outcomes for women with early-stage breast cancer that is hormone-receptor positive. The goal is to see if this combination is more effective and safe than hormone therapy alone.
Fuzhou, FujianAges 18 years+ - NCT07579936RecruitingPhase 2
SAL056 bone-strengthening treatment for postmenopausal osteoporosis
This study tests a new injectable medication called SAL056 to strengthen bones and prevent fractures in postmenopausal women with osteoporosis. Researchers want to find the best dose and how often to give it.
Beijing, Beijing MunicipalityAges 45–80 - NCT07582432RecruitingPhase 3
Gamunex for Blood Cancer Patients With Low Antibodies
This trial tests whether Gamunex, an antibody replacement therapy, helps patients with chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma who have low immunoglobulin (antibody) levels. The treatment may reduce infections and improve how well the body fights disease.
St. Petersburg, FloridaAges 18 years+ - NCT07584876RecruitingPhase 1
Safety study of a new blood clotting medicine in healthy adults
This is an early-stage safety study testing a new experimental medicine that affects blood clotting in people with no serious health conditions. Researchers want to make sure the medicine is safe and well-tolerated before testing it in patients who need it.
Perth, Western AustraliaAges 18–65 - NCT07580105Recruiting
AI tool to help diagnose breast cancer from MRI scans
This study tests a new artificial intelligence software called Kenko Breast AI+ that analyzes breast MRI scans to help doctors better detect and monitor breast cancer. If you've had or are planning to have a breast MRI for cancer concerns, this trial might be right for you.
Elche, AlicanteAges 18 years+ - NCT07582809Recruiting
Digital therapy app for long-term insomnia relief
This study tests a smartphone app called BELL-001 that delivers digital therapy to help people with insomnia sleep better. It looks at how safe and effective the app is over a long period, and may offer an alternative to sleep medications.
IncheonAges 19–75 - NCT07583056Recruiting
Brain Stimulation Treatment for Fibromyalgia Pain
This study tests whether a non-invasive brain stimulation treatment called tDCS (transcranial direct current stimulation) can help reduce fibromyalgia pain. You'll use a small device at home that sends mild electrical currents to your scalp, and researchers will monitor your progress via video calls.
ValenciaAges 18 years+ - NCT07580586RecruitingPhase 1
Study of BV100's effect on polymyxin B in healthy volunteers
This early-stage study tests how a new drug called BV100 affects how your body processes polymyxin B, an antibiotic. Researchers want to understand how these two drugs interact so they can develop safer treatments.
ViennaAges 18–55 - NCT07579234RecruitingPhase 3
New drug F182112 for hard-to-treat multiple myeloma
This trial tests a new drug called F182112 against standard treatments for multiple myeloma that has stopped responding to previous therapies. The goal is to see if F182112 works better and is safe for patients whose cancer has become resistant to multiple drug classes.
TianjingAges 18 years+ - NCT07578753Enrolling by invitation
Robot-assisted walking therapy for burn and fracture recovery
This study tests whether a robotic device that helps you walk can improve movement and function after you've had a severe burn and broken bone in your leg. The robot guides your leg through walking motions while you're healing, and researchers want to see if it helps you regain strength and independence faster.
SeoulAges 18–70 - NCT07582848Recruiting
Breastfeeding Support for Babies with Heart Disease
This study helps mothers of babies born with heart defects learn to breastfeed directly, even when the baby needs heart surgery in the first month of life. Researchers want to see if direct breastfeeding improves health outcomes for both mother and baby during this critical time.
Phoenix, ArizonaAges 18 years+ - NCT07579208RecruitingPhase 1
CAR NK cells for recurrent glioblastoma brain tumors
This trial tests engineered immune cells (called NK cells) that are designed to fight glioblastoma, a deadly brain cancer. The cells are injected directly into the tumor and may help patients whose cancer has come back after standard treatment.
Houston, TexasAges 18 years+ - NCT07584356Recruiting
Comparing Shoulder Replacement Methods for Arthritis
This study compares two different surgical approaches for replacing a shoulder damaged by arthritis, but only in patients whose rotator cuff (the muscles that stabilize the shoulder) is still working well. The goal is to find which method works better for your specific situation.
Rochester, MinnesotaAges 60–85
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,435 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.